Literature DB >> 19568913

Hiroshima survivors exposed to very low doses of A-bomb primary radiation showed a high risk for cancers.

Tomoyuki Watanabe1, Masaru Miyao, Ryumon Honda, Yuichi Yamada.   

Abstract

OBJECTIVES: The aim of this study was to compare the risk for cancers of A-bomb survivors in the ongoing life span study (LSS) with unexposed groups consisting of the entire populations of Hiroshima prefecture and neighboring Okayama prefecture.
METHODS: The subjects consisted of the Hiroshima group reported in LSS report 12 (LSS-H group) and a control group (the entire populations of Hiroshima and Okayama-HPCG and OPCG, respectively). We estimated the expected number of deaths due to all causes and to cancers of various causes among the exposed survivors of the Hiroshima bombing in the LSS report 12 who died in the follow-up interval at ages similar to those of people in Hiroshima and Okayama prefectures who were aged 0-34 years at the time of the bombing in 1945. We compared the standardized mortality ratio (SMR) of the LSS-H group to that of the HPCG and OPCG (SMR-H and SMR-O, respectively).
RESULTS: Even at low and very low dose categories, the SMR-H and SMR-O were significantly high for all deaths, all cancers, solid cancers, and liver cancers in male subjects, and for uterus and liver cancers in female subjects, respectively. The results show that, if the dose estimations of the dosimetry system 1986 (DS86) are correct, there are significantly increased risks of cancer among even survivors exposed to the very low dose level.
CONCLUSIONS: The dose assumptions of DS86 have been criticized for underestimating doses in areas distant from the hypocenter. The contribution of residual radiation, ignored in LSS, and that of neutrons, underestimated by DS86, is suggested to be fairly high.

Entities:  

Year:  2008        PMID: 19568913      PMCID: PMC2698250          DOI: 10.1007/s12199-008-0039-8

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  8 in total

1.  137Cs concentration in soil samples from an early survey of Hiroshima atomic bomb and cumulative dose estimation from the fallout.

Authors:  K Shizuma; K Iwatani; H Hasai; M Hoshi; T Oka; M Okano
Journal:  Health Phys       Date:  1996-09       Impact factor: 1.316

2.  Dose revision for A-bomb survivors and the question of fallout contribution.

Authors:  I Schmitz-Feuerhake
Journal:  Health Phys       Date:  1983-06       Impact factor: 1.316

3.  The effect of diagnostic misclassification on non-cancer and cancer mortality dose response in A-bomb survivors.

Authors:  R Sposto; D L Preston; Y Shimizu; K Mabuchi
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

4.  Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.

Authors:  D A Pierce; Y Shimizu; D L Preston; M Vaeth; K Mabuchi
Journal:  Radiat Res       Date:  1996-07       Impact factor: 2.841

5.  The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.

Authors:  D L Preston; D A Pierce
Journal:  Radiat Res       Date:  1988-06       Impact factor: 2.841

6.  [Symposium: Epidemiology of leukemia in Japan. Leukemia in atomic bomb survivors. 1. Hiroshima, 1946-1967].

Authors:  F Hirose
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1968-10

7.  Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.

Authors:  Y Shimizu; H Kato; W J Schull; D L Preston; S Fujita; D A Pierce
Journal:  Radiat Res       Date:  1989-06       Impact factor: 2.841

8.  Agreement between death certificate and autopsy diagnoses among atomic bomb survivors.

Authors:  E Ron; R Carter; S Jablon; K Mabuchi
Journal:  Epidemiology       Date:  1994-01       Impact factor: 4.822

  8 in total
  10 in total

1.  Thyroid cancer after chernobyl: obfuscated truth.

Authors:  Sergei V Jargin
Journal:  Dose Response       Date:  2011-02-25       Impact factor: 2.658

2.  Radiation unlikely to be responsible for high cancer rates among distal Hiroshima A-bomb survivors.

Authors:  Eric J Grant; Yukiko Shimizu; Fumiyoshi Kasagi; Harry M Cullings; Roy E Shore
Journal:  Environ Health Prev Med       Date:  2009-05-02       Impact factor: 3.674

3.  The issue of exposure to residual radiation of A-bomb survivors with estimates of very low primary radiation dose.

Authors:  Yoshisada Shibata
Journal:  Environ Health Prev Med       Date:  2009-01-29       Impact factor: 3.674

4.  Answer to the comments by Eric J. Grant et al. in "Radiation unlikely to be responsible for high cancer rates among distal Hiroshima A-bomb survivors".

Authors:  Masaru Miyao; Tomoyuki Watanabe; Ryumon Honda; Yuichi Yamada
Journal:  Environ Health Prev Med       Date:  2009-05-02       Impact factor: 3.674

5.  Answer to the comment by Yoshisada Shibata on "Hiroshima survivors exposed to very low doses of A-bomb primary radiation showed a high risk for cancers".

Authors:  Masaru Miyao; Tomoyuki Watanabe; Ryumon Honda; Yuichi Yamada
Journal:  Environ Health Prev Med       Date:  2009-01-29       Impact factor: 3.674

6.  Response to Busby.

Authors:  Bertrand R Jordan
Journal:  Genetics       Date:  2016-12       Impact factor: 4.562

7.  Letter to the Editor on "The Hiroshima/Nagasaki Survivor Studies: Discrepancies Between Results and General Perception" by Bertrand R. Jordan.

Authors:  Christopher Busby
Journal:  Genetics       Date:  2016-12       Impact factor: 4.562

8.  Cancer mortality among atomic bomb survivors exposed as children.

Authors:  Hitomi Goto; Tomoyuki Watanabe; Masaru Miyao; Hiromi Fukuda; Yuzo Sato; Yoshiharu Oshida
Journal:  Environ Health Prev Med       Date:  2011-10-25       Impact factor: 3.674

Review 9.  Cancer risk at low doses of ionizing radiation: artificial neural networks inference from atomic bomb survivors.

Authors:  Masao S Sasaki; Akira Tachibana; Shunichi Takeda
Journal:  J Radiat Res       Date:  2013-12-22       Impact factor: 2.724

Review 10.  Non-Hodgkin lymphomas and ionizing radiation: case report and review of the literature.

Authors:  Inge Schmitz-Feuerhake; Rainer Frentzel-Beyme; Roland Wolff
Journal:  Ann Hematol       Date:  2021-12-08       Impact factor: 3.673

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.